fda glp-1 warning news september 2025 takes aim at telehealth companies for promoting unofficial weight loss drug dupes FDA Sends Warning Letters to

By promoting telomere elongation, Epitalon supports continued cellular replication and genomic integrity

The first step is talking to a healthcare provider if you have concerns about your weight and your health

When we can educate patients appropriately up front about all of their different options and their care along with their providers, they feel like they have more control

Building a Sustainable Long-Term Weight Loss Plan Restarting GLP-1 therapy after a plateau requires a comprehensive approach: genetic testing to clarify your peptide-pathway response, medication selection or adjustment based on that data, lifestyle reinforcement (nutrition, sleep, movement), and regular progress monitoring

The Gut Microbiota as a Therapeutic Target in IBD and Metabolic Disease: A Role for the Bile Acid Receptors FXR and TGR5